Exact Sciences

441 Charmany Dr., Madison, WI 53719

Healthcare & Pharmaceuticals - Diagnostic Laboratories
around $50 - 100M
around 500 - 1K
(608) 284-5700
(608) 284-5701

Exact Sciences Corporation (Exact) is a molecular diagnostics company focused on the early detection and prevention of colorectal cancer. The Company's non-invasive stool-based deoxyribonucleic acid (sDNA) screening technology includes methods that isolate and analyze human DNA present in stool to screen for the presence of colorectal pre-cancer and cancer. The Company has an intellectual property protecting its non-invasive, molecular screening technology for the detection of colorectal pre-cancer and cancer. The Company?s Cologuard test includes DNA markers. In addition to DNA markers, its test will also include a protein marker to detect blood in the stool, utilizing an antibody-based fecal immunochemical test (FIT). Its Cologuard test is designed to detect pre-cancerous lesions or poly... (Source: SEC reports)

Competitor - 1/8
Which company is more competitive with Exact Sciences?

147 Contacts at this company
Melissa Gray
Research Scientist
Andrew Brogaard
Senior Operations Scientist
Alfred Nehme
Assistant Professor Of Computer Science ...
Lynn Moffett
Vice President of Market Development ...
Janelle Bruinsma
Director Product Development
Michele Merritt
VP, Commercial Development
Sandra Statz
Vice President, Clinical & Regulatory ...
Mary Lynne Hasty, MBA, ATC
Clinical Study Manager ...
Joel Schriever
Senior Director, Facilities and ...

Mar 20, 2018 18:14:50
MADISON, Wis., March 20, 2018 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS), the company that developed and commercialized Cologuard®, the only FDA-approved, noninvasive stool DNA-based test for early [...]

Mar 11, 2018 17:54:22
MADISON, Wis., March 6, 2018 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that Paul J. Limburg, M.D., M.P.H., has been appointed the company\'s co-chief medical officer. [...]

Jul 21, 2017 20:43:23
MADISON, Wis., July 21, 2017 /PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS) today announced that, in support of the Company\'s continued growth plans, it granted restricted stock units [...]

Jun 22, 2017 20:48:41
MADISON, Wis., June 22, 2017 /PRNewswire/ -- Exact Sciences today announced it is teaming up with Madison professional golfer Jerry Kelly to help drive home the importance of colorectal cancer screening.  [...]

Jun 6, 2017 20:42:32
MADISON, Wis., June 6, 2017 /PRNewswire/ -- Exact Sciences Corporation (NASDAQ: EXAS) today announced an agreement to sell 7,000,000 shares of its common stock to Jefferies LLC, BofA [...]

Get Started Today : Sign up in 20 seconds
Search with 20+ criteria.
Export results in seconds.
Bad emails?
No worry, we give two extras for every bad email.